Nanoscale

PloS one

Acta biomaterialia

Frontiers in microbiology

British journal of clinical pharmacology

PLoS genetics

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

bratislavske lekarske listy

Minerva anestesiologica

American journal of ophthalmology

The Review of scientific instruments

clinical microbiology and infection : the official publication of the european society of clinical microbiology and infectious diseases

pharmacy practice

Transplantation proceedings

the journal of political economy

revista espanola de quimioterapia : publicacion oficial de la sociedad espanola de quimioterapia

the journal of family practice

coronary artery disease

[1] Ultrasound-triggered antibiotic release from PEEK clips to prevent spinal fusion infection: Initial evaluations.

[2] Infective endocarditis caused by Streptococcus acidominimus.

[3] Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Bacteria in a Hollow Fiber Infection Model.

[4] Vancomycin - Audit of American guideline-based intermittent dose administration with focus on overweight patients.

[5] When guideline treatment of asthma fails, consider a macrolide antibiotic.

[6] Poor nutrition for under-five children from poor households in Ethiopia: Evidence from 2016 Demographic and Health Survey.

[7] Racial discrimination in medical care settings and opioid pain reliever misuse in a U.S. cohort: 1992 to 2015.

[8] Crossover interference and sex-specific genetic maps shape identical by descent sharing in close relatives.

[9] Interaction of tobacco smoking and alcohol consumption with obesity on cardiovascular disease in a Chinese cohort.

[10] Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

[11] Acute kidney injury following the concurrent administration of antipseudomonal beta-lactams and vancomycin: a network meta-analysis.

[12] Prognostic Value of Creatinine Concentration and Glomerular Filtration Rate in Acute Kidney Injury Development in the Early Postoperative Period After Heart Transplantation.

[13] Association of Cardiovascular Mortality and Deep Learning-Funduscopic Atherosclerosis Score derived from Retinal Fundus Images.

[14] In Situ Gelling Hydrogel with Anti-Bacterial Activity and Bone Healing Property for Treatment of Osteomyelitis

[15] thusin, a novel two-component lantibiotic with potent antimicrobial activity against several gram-positive pathogens

[16] aloinjerto fresco congelado en cirugía de columna lumbar. ¿aumenta la tasa de infección? [fresh frozen allograft in lumbar spine surgery. does it increase the rate of infection?]

[17] vancomycin-induced stevens-johnson syndrome in a boy under 2 years old: an early diagnosis by granulysin rapid test

[18] enterococcus spp. resistentes à vancomicina isolados de fezes de frangos, pombos, gamos e ratos vancomycin-resistant enterococcus isolated from feces of poultry, pigeons, deers and rats

[19] the need to assay the real mic when making the decision to eradicate staphylococcus aureus with vancomycin

[20] vancomycin treatment: analysis of efficacy and safety

[21] icariin enhances bone repair in rabbits with bone infection during post-infection treatment and prevents inhibition of osteoblasts by vancomycin

[22] evaluation of methods in detecting vancomycin mic among mrsa isolates and the changes in accuracy related to different mic values

[23] Use of Artificial Intelligence in Current Fight Against Antimicrobial Resistance.

[24] Antibiofilm formation and wound healing activity of glycopeptide antibiotic vancomycin against skin Pathogens

[25] Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus

[26] High dose of vancomycin plus gentamicin incorporated acrylic bone cement decreased the elution of vancomycin

[27] Vancomycin-resistant enterococcal infection in a Thai university hospital: clinical characteristics, treatment outcomes, and synergistic effect

[28] Genetic characterization of two vancomycin-resistant Staphylococcus aureus isolates in Kerman, Iran

[29] Vancomycin in the treatment of adult intra-abdominal infections: do we have strong evidences?

[30] Vancomycin trough level and loading dose

[31] Molecular detection of vanA and vanB genes among vancomycin-resistant enterococci in ICU-hospitalized patients in Ahvaz in southwest of Iran

[32] Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

[33] Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus

[34] Chlorhexidine-based body washing for colonization and infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: an updated meta-analysis

[35] Extremely high levels of vancomycin can cause severe renal toxicity

[36] Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus

[37] The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock

[38] Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

[39] Evaluating vancomycin susceptibility in Staphylococcus aureus

[40] Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range

[41] Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management

[42] An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

[43] Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen

[44] Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus

[45] High dose of vancomycin plus gentamicin incorporated acrylic bone cement decreased the elution of vancomycin

[46] Vancomycin-resistant enterococcal infection in a Thai university hospital: clinical characteristics, treatment outcomes, and synergistic effect

[47] Genetic characterization of two vancomycin-resistant Staphylococcus aureus isolates in Kerman, Iran

[48] Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus

[49] High dose of vancomycin plus gentamicin incorporated acrylic bone cement decreased the elution of vancomycin

[50] Vancomycin-resistant enterococcal infection in a Thai university hospital: clinical characteristics, treatment outcomes, and synergistic effect

[51] Genetic characterization of two vancomycin-resistant Staphylococcus aureus isolates in Kerman, Iran

[52] Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Masquerading as Elusive Sepsis

[53] Vancomycin in the treatment of adult intra-abdominal infections: do we have strong evidences?

[54] Vancomycin trough level and loading dose

[55] Molecular detection of vanA and vanB genes among vancomycin-resistant enterococci in ICU-hospitalized patients in Ahvaz in southwest of Iran

[56] Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

[57] Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus

[58] Chlorhexidine-based body washing for colonization and infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: an updated meta-analysis

[59] Extremely high levels of vancomycin can cause severe renal toxicity

[60] Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus

[61] The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock

[62] Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

[63] Evaluating vancomycin susceptibility in Staphylococcus aureus

[64] Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range

[65] Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management

[66] An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

[67] Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen

[68] The alpha-2 receptor agonist dexmedetomidine attenuates vancomycin‑induced acute kidney injury.

[69] Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.

[70] Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients.

[71] Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients

[72] Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA).

[73] Vancomycin and florfenicol resistant Enterococcus faecalis and Enterococcus faecium isolated from human urine in an Egyptian urban-rural community.

[74] Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

[75] Metal-organic frameworks for on-demand pH controlled delivery of vancomycin from chitosan scaffolds.

[76] Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Bacteria in a Hollow Fiber Infection Model.

[77] Vancomycin - Audit of American guideline-based intermittent dose administration with focus on overweight patients.

[78] Multiomics Substrates of Resistance to Emerging Pathogens? Transcriptome and Proteome Profile of a Vancomycin-Resistant Clinical Strain.

[79] Are cefuroxime and vancomycin really safe on the corneal endothelial cells?

[80] Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections.

[81] Acute kidney injury following the concurrent administration of antipseudomonal beta-lactams and vancomycin: a network meta-analysis.

[82] Vancomycin HCl-loaded lauric acid in situ-forming gel with phase inversion for periodontitis treatment

[83] Staphylococcus aureus resistant to vancomycin--United States, 2002

[84] Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002

[85] Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus

[86] Emergence of vancomycin resistance in coagulase-negative staphylococci

[87] Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

[88] Coexistence of Vancomycin-Resistant Enterococci and Staphylococcus aureus in the Intestinal Tracts of Hospitalized Patients

[89] Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections

[90] Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

[91] Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

[92] Outbreak of Vancomycin-resistant Enterococcus faecium in Interventional Radiology: Detection Through Whole-genome Sequencing-based Surveillance

[93] Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin

[94] modified pap method to detect heteroresistance to vancomycin among methicillin resistant <i> staphylococcus aureus</i> isolates at a tertiary care hospital

[95] a promising approach to provide appropriate colon target drug delivery systems of vancomycin hcl: pharmaceutical and microbiological studies

[96] preparation and characterization of vancomycin-loaded electrospun rana chensinensis skin collagen/poly(l-lactide) nanofibers for drug delivery

[97] junior doctors’ preparedness to prescribe, monitor, and treat patients with the antibiotic vancomycin in an australian teaching hospital

[98] our experiences with vancomycin-resistant enterococci in jesenice general hospital

[99] internalization of staphylococcus aureus in lymphocytes induces oxidative stress and dna fragmentation: possible ameliorative role of nanoconjugated vancomycin

[100] identification and molecular characterization of van a-type vancomycin-resistant enterococcus faecalis in northeast of brazil

[101] pharmacokinetic properties and systemic safety of vancomycin-impregnated cancellous bone grafts in the treatment of spondylodiscitis